-
Something wrong with this record ?
p53 Specifically Binds Triplex DNA In Vitro and in Cells
M. Brázdová, V. Tichý, R. Helma, P. Bažantová, A. Polášková, A. Krejčí, M. Petr, L. Navrátilová, O. Tichá, K. Nejedlý, ML. Bennink, V. Subramaniam, Z. Bábková, T. Martínek, M. Lexa, M. Adámik,
Language English Country United States
Document type Journal Article
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-10-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Transcriptional Activation genetics MeSH
- DNA-Binding Proteins chemistry genetics MeSH
- DNA chemistry genetics MeSH
- Nucleic Acid Conformation MeSH
- Humans MeSH
- Tumor Suppressor Protein p53 chemistry genetics MeSH
- Nucleotide Motifs genetics MeSH
- Plasmids genetics MeSH
- Promoter Regions, Genetic MeSH
- Regulatory Sequences, Nucleic Acid genetics MeSH
- Sequence Deletion genetics MeSH
- Binding Sites MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Triplex DNA is implicated in a wide range of biological activities, including regulation of gene expression and genomic instability leading to cancer. The tumor suppressor p53 is a central regulator of cell fate in response to different type of insults. Sequence and structure specific modes of DNA recognition are core attributes of the p53 protein. The focus of this work is the structure-specific binding of p53 to DNA containing triplex-forming sequences in vitro and in cells and the effect on p53-driven transcription. This is the first DNA binding study of full-length p53 and its deletion variants to both intermolecular and intramolecular T.A.T triplexes. We demonstrate that the interaction of p53 with intermolecular T.A.T triplex is comparable to the recognition of CTG-hairpin non-B DNA structure. Using deletion mutants we determined the C-terminal DNA binding domain of p53 to be crucial for triplex recognition. Furthermore, strong p53 recognition of intramolecular T.A.T triplexes (H-DNA), stabilized by negative superhelicity in plasmid DNA, was detected by competition and immunoprecipitation experiments, and visualized by AFM. Moreover, chromatin immunoprecipitation revealed p53 binding T.A.T forming sequence in vivo. Enhanced reporter transactivation by p53 on insertion of triplex forming sequence into plasmid with p53 consensus sequence was observed by luciferase reporter assays. In-silico scan of human regulatory regions for the simultaneous presence of both consensus sequence and T.A.T motifs identified a set of candidate p53 target genes and p53-dependent activation of several of them (ABCG5, ENOX1, INSR, MCC, NFAT5) was confirmed by RT-qPCR. Our results show that T.A.T triplex comprises a new class of p53 binding sites targeted by p53 in a DNA structure-dependent mode in vitro and in cells. The contribution of p53 DNA structure-dependent binding to the regulation of transcription is discussed.
Department of Information Technologies Faculty of Informatics Masaryk University Brno Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17031249
- 003
- CZ-PrNML
- 005
- 20240117115321.0
- 007
- ta
- 008
- 171025s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0167439 $2 doi
- 035 __
- $a (PubMed)27907175
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Brázdová, Marie $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 245 10
- $a p53 Specifically Binds Triplex DNA In Vitro and in Cells / $c M. Brázdová, V. Tichý, R. Helma, P. Bažantová, A. Polášková, A. Krejčí, M. Petr, L. Navrátilová, O. Tichá, K. Nejedlý, ML. Bennink, V. Subramaniam, Z. Bábková, T. Martínek, M. Lexa, M. Adámik,
- 520 9_
- $a Triplex DNA is implicated in a wide range of biological activities, including regulation of gene expression and genomic instability leading to cancer. The tumor suppressor p53 is a central regulator of cell fate in response to different type of insults. Sequence and structure specific modes of DNA recognition are core attributes of the p53 protein. The focus of this work is the structure-specific binding of p53 to DNA containing triplex-forming sequences in vitro and in cells and the effect on p53-driven transcription. This is the first DNA binding study of full-length p53 and its deletion variants to both intermolecular and intramolecular T.A.T triplexes. We demonstrate that the interaction of p53 with intermolecular T.A.T triplex is comparable to the recognition of CTG-hairpin non-B DNA structure. Using deletion mutants we determined the C-terminal DNA binding domain of p53 to be crucial for triplex recognition. Furthermore, strong p53 recognition of intramolecular T.A.T triplexes (H-DNA), stabilized by negative superhelicity in plasmid DNA, was detected by competition and immunoprecipitation experiments, and visualized by AFM. Moreover, chromatin immunoprecipitation revealed p53 binding T.A.T forming sequence in vivo. Enhanced reporter transactivation by p53 on insertion of triplex forming sequence into plasmid with p53 consensus sequence was observed by luciferase reporter assays. In-silico scan of human regulatory regions for the simultaneous presence of both consensus sequence and T.A.T motifs identified a set of candidate p53 target genes and p53-dependent activation of several of them (ABCG5, ENOX1, INSR, MCC, NFAT5) was confirmed by RT-qPCR. Our results show that T.A.T triplex comprises a new class of p53 binding sites targeted by p53 in a DNA structure-dependent mode in vitro and in cells. The contribution of p53 DNA structure-dependent binding to the regulation of transcription is discussed.
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a DNA $x chemie $x genetika $7 D004247
- 650 _2
- $a DNA vazebné proteiny $x chemie $x genetika $7 D004268
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a konformace nukleové kyseliny $7 D009690
- 650 _2
- $a nukleotidové motivy $x genetika $7 D059372
- 650 _2
- $a plazmidy $x genetika $7 D010957
- 650 _2
- $a promotorové oblasti (genetika) $7 D011401
- 650 _2
- $a regulační oblasti nukleových kyselin $x genetika $7 D012045
- 650 _2
- $a sekvenční delece $x genetika $7 D017384
- 650 _2
- $a aktivace transkripce $x genetika $7 D015533
- 650 _2
- $a nádorový supresorový protein p53 $x chemie $x genetika $7 D016159
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tichý, Vlastimil $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Helma, Robert $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic. $7 xx0312816
- 700 1_
- $a Bažantová, Pavla $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Polášková, Alena $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Krejčí, Aneta $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 700 1_
- $a Petr, Marek $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Navrátilová, Lucie $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Tichá, Olga $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Nejedlý, Karel $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic.
- 700 1_
- $a Bennink, Martin L $u Biophysical Engineering Group, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.
- 700 1_
- $a Subramaniam, Vinod $u Biophysical Engineering Group, Faculty of Science and Technology, University of Twente, Enschede, The Netherlands.
- 700 1_
- $a Bábková, Zuzana $u Department of Molecular Biology and Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Brno, Czech Republic.
- 700 1_
- $a Martínek, Tomáš $u Department of Computer Systems, Faculty of Information Technology, Brno University of Technology, Brno, Czech Republic.
- 700 1_
- $a Lexa, Matej $u Department of Information Technologies, Faculty of Informatics, Masaryk University, Brno, Czech Republic.
- 700 1_
- $a Adámik, Matej $u Department of Biophysical Chemistry and Molecular Oncology, Institute of Biophysics, Academy of Sciences of the Czech Republic v.v.i., Brno, Czech Republic. $7 gn_A_00001382
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 11, č. 12 (2016), s. e0167439
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27907175 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20171025 $b ABA008
- 991 __
- $a 20240117115317 $b ABA008
- 999 __
- $a ok $b bmc $g 1254842 $s 992276
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 11 $c 12 $d e0167439 $e 20161201 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20171025